| ASSET | YEAR | % RETURN |
|---|---|---|
Viking Therapeutics (VKTX) | 2015 | -59.88% |
Viking Therapeutics (VKTX) | 2016 | -64.26% |
Viking Therapeutics (VKTX) | 2017 | 238.33% |
Viking Therapeutics (VKTX) | 2018 | 87.04% |
Viking Therapeutics (VKTX) | 2019 | 8.38% |
Viking Therapeutics (VKTX) | 2020 | -31.76% |
Viking Therapeutics (VKTX) | 2021 | -19.3% |
Viking Therapeutics (VKTX) | 2022 | 101.28% |
Viking Therapeutics (VKTX) | 2023 | 102.5% |
Viking Therapeutics (VKTX) | 2024 | 117.16% |
Viking Therapeutics (VKTX) | 2025 | -29.85% |
